盐酸氯环嗪
盐酸氯环嗪用途
Chlorcyclizine hydrochloride 是一种组胺 H1 拮抗剂。
点击显示
盐酸氯环嗪名称
[ CAS 号 ]:
14362-31-3
[ 中文名 ]:
盐酸氯环嗪
[ 英文名 ]:
chlorcyclizine hydrochloride
[中文别名 ]:
[英文别名 ]:
- Ah-289 hydrochloride
- hydroxyzine hydrochloride
- CHLORCYCLIZINE HCL
- Chlorocyclizine hydrochloride
- di-paralene
- Component of fedrazil
- eramide
- Perazil
- chlorcycliziniumchloride
- chlorocyclizine HCl
盐酸氯环嗪生物活性
[ 描述 ]:
Chlorcyclizine hydrochloride 是一种组胺 H1 拮抗剂。
[ 相关类别 ]:
[ 靶点 ]
Histamine H1[1]
[体内研究]
怀孕大鼠在腭发育的敏感期内给予30,60和90mg/kg氯环嗪,直至妊娠日(GDs)17或21的预定处死。给予60或90mg/kg氯环嗪的大鼠具有短暂的不良临床症状(牙釉质,在给药间隔期间,红色口周物质,泌尿生殖器染色和少量粪便)和伴随的体重减轻分别为7％和11％。施用30mg/kg氯环嗪的大鼠没有表现出任何不利的临床症状,但是在妊娠期间预期的剂量间隔不增加体重。基于测试设施的历史控制数据库(16项研究,n = 380)。怀孕的大鼠通常从GDs 12到15获得约6％的体重[1]。
[动物实验]
大鼠[1]使用定时配对的CRL：CD-SD雌性大鼠，其在给药开始时在9至13周龄之间并且重量在245至363g之间。在口腔发育的敏感期，大鼠每日口服管饲剂量为30,60或90 mg / kg氯环嗪（n = 8 /组），GDs 11至14.这些剂量选择为30 mg / kg可能是无效剂量，60和/或90mg / kg的较高剂量将诱导胎儿腭裂的中度或高发生率。鉴于CRL：CDs [SD]大鼠在测试实验室中自发性腭裂的发生率极低，并且为了避免不必要的动物使用，省略了甲基纤维素对照组[1]。
[参考文献]
[相关活性小分子]
盐酸氯环嗪物理化学性质
[ 密度 ]:
1.145g/cm3
[ 沸点 ]:
393.6ºC at 760mmHg
[ 分子式 ]:
C18H22Cl2N2
[ 分子量 ]:
337.287
[ 闪点 ]:
191.9ºC
[ 精确质量 ]:
336.115997
[ PSA ]:
6.48000
[ LogP ]:
4.35460
[ 蒸汽压 ]:
2.1E-06mmHg at 25°C
[ 折射率 ]:
1.59
[ 储存条件 ]:
库房低温通风干燥,与食品原料分开存放
盐酸氯环嗪MSDS
盐酸氯环嗪毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- TL2200000
- CHEMICAL NAME :
- Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-, hydrochloride
- CAS REGISTRY NUMBER :
- 14362-31-3
- LAST UPDATED :
- 199509
- DATA ITEMS CITED :
- 18
- MOLECULAR FORMULA :
- C18-H21-Cl-N2.Cl-H
- MOLECULAR WEIGHT :
- 337.32
- WISWESSER LINE NOTATION :
- T6N DNTJ AYR&R DG& D &GH
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 300 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 35 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 125 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 75 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- 27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,213,1972
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada) ** OTHER MULTIPLE DOSE TOXICITY DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 840 mg/kg/2W-I
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - other changes Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Metabolism (Intermediary) - lipids including transport
- REFERENCE :
- TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 65,100,1982 ** REPRODUCTIVE DATA **
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 240 mg/kg
- SEX/DURATION :
- female 12-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - other effects to embryo
- REFERENCE :
- TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 18,199,1978
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 100 mg/kg
- SEX/DURATION :
- female 12-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - homeostasis
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 147,391,1965
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 500 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- REFERENCE :
- TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 8,87,1977
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 3024 mg/kg
- SEX/DURATION :
- male 28 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - testes, epididymis, sperm duct Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland, accessory glands
- REFERENCE :
- BIREBV Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL 61820) V.1- 1969- Volume(issue)/page/year: 7,398,1972
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 650 mg/kg
- SEX/DURATION :
- female 10-22 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - postpartum Reproductive - Effects on Newborn - physical
- REFERENCE :
- VAAZA2 Virchows Archiv, Abteilung B: Cell Pathology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.1- 1968- Volume(issue)/page/year: 39,59,1982
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 400 mg/kg
- SEX/DURATION :
- female 13-16 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- REFERENCE :
- FCTXAV Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see FCTOD7. Volume(issue)/page/year: 10,839,1972
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 800 mg/kg
- SEX/DURATION :
- female 11-14 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- REFERENCE :
- AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 95,109,1966
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intramuscular
- DOSE :
- 200 mg/kg
- SEX/DURATION :
- female 12-13 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - eye/ear
- REFERENCE :
- AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 194,168,1971
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intramuscular
- DOSE :
- 200 mg/kg
- SEX/DURATION :
- female 12-13 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- REFERENCE :
- AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 194,168,1971
点击显示
盐酸氯环嗪安全信息
[ 符号 ]:
GHS06
[ 信号词 ]:
Danger
[ 危害声明 ]:
H301-H315-H319-H335
[ 警示性声明 ]:
Missing Phrase - N15.00950417-P305 + P351 + P338
[ 危害码 (欧洲) ]:
T
[ 风险声明 (欧洲) ]:
61-22
[ 安全声明 (欧洲) ]:
53-22-36/37/39-45
[ 危险品运输编码 ]:
UN 2811 6.1 / PGIII
[ 海关编码 ]:
2933599090
盐酸氯环嗪海关
[ 海关编码 ]: 2933599090
[ 中文概述 ]:
2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期
[ Summary ]:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
相关药品：
推荐生产厂家/供应商：
公司名：上海脉铂医药科技有限公司
区域：上海市嘉定区
价格：
￥4077.0/500mg
￥2131.0/250mg
￥7227.0/1g
￥899.0/1mg
联系人：李先生
产品详情：Chlorcyclizine (hydrochloride)
公司名：上海创赛科技有限公司
区域：上海市嘉定区
价格：
￥832.0/100mg
￥1307.0/200mg
￥4006.24/500mg
￥2099.16/250mg
联系人：夏言
产品详情：[Perfemiker]Chlorcyclizine hydrochloride,≥99%
公司名：上海陌孚医药科技有限公司
区域：上海市嘉定区
价格：
￥1889.24/250mg
￥802.62/100mg
￥3605.62/500mg
￥6383.92/1g
联系人：朱经理
产品详情：Chlorcyclizine (hydrochloride)
查看所有供应商请点击：
相关化合物
【盐酸氯环嗪】化源网提供盐酸氯环嗪CAS号14362-31-3，盐酸氯环嗪MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询盐酸氯环嗪上化源网，专业又轻松。>>电脑版：盐酸氯环嗪
标题：盐酸氯环嗪_MSDS_用途_密度_盐酸氯环嗪CAS号【14362-31-3】_化源网 地址：https://m.chemsrc.com/mip/cas/14362-31-3_1032464.html